交易 Better Therapeutics, Inc. - BTTX CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.0562 | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
May 26, 2023 | 0.6830 | 0.0159 | 2.38% | 0.6671 | 0.7263 | 0.6480 |
May 25, 2023 | 0.6683 | -0.0257 | -3.70% | 0.6940 | 0.7422 | 0.6483 |
May 24, 2023 | 0.7168 | -0.0290 | -3.89% | 0.7458 | 0.7459 | 0.6924 |
May 23, 2023 | 0.7507 | 0.0054 | 0.72% | 0.7453 | 0.7651 | 0.7453 |
May 22, 2023 | 0.7555 | 0.0201 | 2.73% | 0.7354 | 0.7942 | 0.7354 |
May 19, 2023 | 0.7564 | 0.0013 | 0.17% | 0.7551 | 0.7747 | 0.7540 |
May 18, 2023 | 0.7554 | -0.0015 | -0.20% | 0.7569 | 0.7845 | 0.7356 |
May 17, 2023 | 0.7582 | 0.0126 | 1.69% | 0.7456 | 0.7797 | 0.7456 |
May 16, 2023 | 0.7620 | -0.0388 | -4.85% | 0.8008 | 0.8037 | 0.7260 |
May 15, 2023 | 0.7457 | -0.0580 | -7.22% | 0.8037 | 0.8136 | 0.7359 |
May 12, 2023 | 0.7470 | 0.0310 | 4.33% | 0.7160 | 0.7749 | 0.7159 |
May 11, 2023 | 0.7555 | -0.0823 | -9.82% | 0.8378 | 0.8571 | 0.7257 |
May 10, 2023 | 0.8349 | 0.0215 | 2.64% | 0.8134 | 0.8716 | 0.7544 |
May 9, 2023 | 0.8039 | 0.0391 | 5.11% | 0.7648 | 0.8137 | 0.7262 |
May 8, 2023 | 0.7746 | -0.1165 | -13.07% | 0.8911 | 0.8911 | 0.6907 |
May 5, 2023 | 0.9005 | 0.0042 | 0.47% | 0.8963 | 0.9298 | 0.8905 |
May 4, 2023 | 0.9297 | -0.1353 | -12.70% | 1.0650 | 1.0653 | 0.8708 |
May 3, 2023 | 1.0750 | 0.0017 | 0.16% | 1.0733 | 1.1041 | 1.0635 |
May 2, 2023 | 1.0944 | 0.0095 | 0.88% | 1.0849 | 1.1233 | 1.0652 |
May 1, 2023 | 1.0943 | -0.0281 | -2.50% | 1.1224 | 1.1332 | 1.0741 |
Better Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Wednesday, August 9, 2023 | ||
时间(协调世界时) (UTC) 20:00 | 国家 US
| 事件 Q2 2023 Better Therapeutics Inc Earnings Release Q2 2023 Better Therapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
时间(协调世界时) (UTC) 21:00 | 国家 US
| 事件 Q3 2023 Better Therapeutics Inc Earnings Release Q3 2023 Better Therapeutics Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | |
---|---|---|---|
總收入 | 0 | 0 | 0 |
總營業費用 | 38.262 | 40.303 | 0.00169 |
Other Operating Expenses, Total | 0.00169 | ||
營業收入 | -38.262 | -40.303 | -0.00169 |
稅前淨收入 | -39.753 | -40.488 | -0.00169 |
稅後淨收入 | -39.76 | -40.335 | -0.00169 |
未計算非常項目前的淨收益 | -39.76 | -40.335 | -0.00169 |
淨收入 | -39.76 | -40.335 | -0.00169 |
普通股股東可獲收益 (不含非經常性項目) | -39.76 | -40.335 | -0.00169 |
普通股股東可獲收益 (含非經常性項目) | -39.76 | -40.335 | -0.00169 |
攤薄淨收入 | -39.76 | -40.335 | -0.00169 |
攤薄後加權平均股 | 23.5578 | 23.6027 | 7.5575 |
扣除特別項目的每股攤薄盈利 | -1.68776 | -1.70891 | -0.00022 |
Dividends per Share - Common Stock Primary Issue | 0 | ||
每股正常攤薄盈利 | -1.68776 | -1.4406 | -0.00022 |
銷售/一般/行政費用,總計 | 21.822 | 11.124 | |
研究與開發 | 16.44 | 19.436 | |
異常費用(收入) | 0 | 9.743 | |
利息收入(費用),非經營淨值 | -1.491 | -0.185 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 8.925 | 8.322 | 10.996 | 9.599 | 9.345 |
Other Operating Expenses, Total | |||||
營業收入 | -8.925 | -8.322 | -10.996 | -9.599 | -9.345 |
利息收入(費用),非經營淨值 | -0.431 | -0.439 | -0.406 | -0.329 | -0.317 |
稅前淨收入 | -9.356 | -8.761 | -11.402 | -9.928 | -9.662 |
稅後淨收入 | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
未計算非常項目前的淨收益 | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
淨收入 | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
普通股股東可獲收益 (不含非經常性項目) | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
普通股股東可獲收益 (含非經常性項目) | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
攤薄淨收入 | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
攤薄後加權平均股 | 23.8266 | 23.6315 | 23.6931 | 23.593 | 23.4132 |
扣除特別項目的每股攤薄盈利 | -0.39271 | -0.3709 | -0.48136 | -0.4208 | -0.41267 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.39271 | -0.3709 | -0.48136 | -0.4208 | -0.41267 |
銷售/一般/行政費用,總計 | 5.536 | 5.273 | 5.519 | 5.358 | 5.672 |
研究與開發 | 3.389 | 3.049 | 5.477 | 4.241 | 3.673 |
異常費用(收入) | 0 | 0 | 0 | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | |
---|---|---|---|
流動資産總額 | 18.446 | 45.251 | 0.08666 |
現金和短期投資 | 15.74 | 40.566 | 0.02476 |
Cash | 0.02476 | ||
Other Current Assets, Total | 0.21 | 0.276 | 0.06189 |
Total Assets | 22.943 | 50.958 | 0.08666 |
Total Current Liabilities | 13.494 | 4.733 | 0.06334 |
Accrued Expenses | 5.927 | 3.21 | 0.00145 |
Notes Payable/Short Term Debt | 0 | 0 | 0.06189 |
Total Liabilities | 23.842 | 14.238 | 0.06334 |
Total Long Term Debt | 10.348 | 9.505 | 0 |
Total Equity | -0.899 | 36.72 | 0.02331 |
Common Stock | 0.002 | 0.002 | 0.00014 |
Additional Paid-In Capital | 110.602 | 108.461 | 0.02486 |
Retained Earnings (Accumulated Deficit) | -111.503 | -71.743 | -0.00169 |
Total Liabilities & Shareholders’ Equity | 22.943 | 50.958 | 0.08666 |
Total Common Shares Outstanding | 23.851 | 23.6027 | 7.5575 |
現金等價物 | 15.74 | 40.566 | |
Prepaid Expenses | 2.496 | 4.409 | |
Property/Plant/Equipment, Total - Net | 0.121 | 0.082 | |
Intangibles, Net | 3.888 | 5.077 | |
Other Long Term Assets, Total | 0.488 | 0.548 | |
Accounts Payable | 3.035 | 1.523 | |
Long Term Debt | 10.348 | 9.505 | |
Property/Plant/Equipment, Total - Gross | 0.178 | ||
Accumulated Depreciation, Total | -0.057 | ||
Current Port. of LT Debt/Capital Leases | 4.532 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 8.442 | 18.446 | 23.49 | 32.137 | 35.179 |
現金和短期投資 | 6.068 | 15.74 | 22.305 | 29.685 | 31.673 |
Cash | |||||
Prepaid Expenses | 1.968 | 2.496 | 1.123 | 2.38 | 3.242 |
Total Assets | 12.808 | 22.943 | 28.221 | 37.103 | 40.291 |
Long Term Investments | |||||
Other Long Term Assets, Total | 0.483 | 0.488 | 0.488 | 0.487 | 0.488 |
Total Current Liabilities | 13.64 | 13.494 | 9.312 | 6.141 | 3.567 |
Accrued Expenses | 5.588 | 5.927 | 4.928 | 3.27 | 2.528 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 22.641 | 23.842 | 20.969 | 19.049 | 12.866 |
Total Long Term Debt | 9.001 | 10.348 | 11.657 | 12.908 | 9.299 |
Other Liabilities, Total | |||||
Total Equity | -9.833 | -0.899 | 7.252 | 18.054 | 27.425 |
Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 111.025 | 110.602 | 109.988 | 109.385 | 108.828 |
Retained Earnings (Accumulated Deficit) | -120.86 | -111.503 | -102.738 | -91.333 | -81.405 |
Total Liabilities & Shareholders’ Equity | 12.808 | 22.943 | 28.221 | 37.103 | 40.291 |
Total Common Shares Outstanding | 23.8523 | 23.851 | 23.7441 | 23.733 | 23.6086 |
Payable/Accrued | |||||
現金等價物 | 6.068 | 15.74 | 22.305 | 29.685 | 31.673 |
Other Current Assets, Total | 0.406 | 0.21 | 0.062 | 0.072 | 0.264 |
Property/Plant/Equipment, Total - Net | 0.131 | 0.121 | 0.122 | 0.115 | 0.098 |
Intangibles, Net | 3.752 | 3.888 | 4.121 | 4.364 | 4.526 |
Accounts Payable | 2.513 | 3.035 | 1.255 | 1.088 | 0.735 |
Long Term Debt | 9.001 | 10.348 | 11.657 | 12.908 | 9.299 |
Current Port. of LT Debt/Capital Leases | 5.539 | 4.532 | 3.129 | 1.783 | 0.304 |
- 年度
- 每季度
2022 | 2021 | 2020 | |
---|---|---|---|
淨收入/起跑線 | -39.76 | -40.335 | -0.00169 |
經營活動産生的現金 | -28.93 | -30.818 | -0.00024 |
營運資金的變化 | 6.268 | -2.339 | 0.00145 |
融資活動産生的現金 | 5.284 | 72.332 | 0.025 |
融資現金流項目 | 0 | 62.331 | -0.06189 |
股票的發行(報廢),淨額 | 0.284 | 0.001 | 0.025 |
債務的發行(退還),淨額 | 5 | 10 | 0.06189 |
現金淨變化 | -24.826 | 40.443 | 0.02476 |
經營活動産生的現金 | 2.729 | 1.619 | |
Deferred Taxes | 0 | -0.152 | |
非現金物品 | 1.833 | 10.389 | |
已付現金利息 | 1.325 | 0.085 | |
投資活動産生的現金 | -1.18 | -1.071 | |
資本支出 | -1.18 | -1.071 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.357 | -39.76 | -30.995 | -19.59 | -9.662 |
Cash From Operating Activities | -8.716 | -28.93 | -22.593 | -15.57 | -8.855 |
Non-Cash Items | 0.41 | 1.833 | 1.384 | 0.787 | 0.375 |
Changes in Working Capital | -0.524 | 6.268 | 5.01 | 1.919 | -0.231 |
Cash From Investing Activities | -0.521 | -1.18 | -0.82 | -0.457 | -0.039 |
Other Investing Cash Flow Items, Total | |||||
Cash From Financing Activities | -0.435 | 5.284 | 5.152 | 5.146 | 0.001 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0 | 0.284 | 0.152 | 0.146 | 0.001 |
Issuance (Retirement) of Debt, Net | -0.435 | 5 | 5 | 5 | |
Net Change in Cash | -9.672 | -24.826 | -18.261 | -10.881 | -8.893 |
Cash From Operating Activities | 0.755 | 2.729 | 2.008 | 1.314 | 0.663 |
Deferred Taxes | 0 | 0 | 0 | 0 | |
Cash Interest Paid | 0.495 | 1.325 | 0.87 | 0.462 | 0.219 |
Capital Expenditures | -0.521 | -1.18 | -0.82 | -0.457 | -0.039 |
Cash Taxes Paid | 0 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Perry (David P) | Individual Investor | 53.1606 | 16868581 | 6404566 | 2023-04-12 | LOW |
Georgianna Maule-Ffinch 2015 Trust | Individual Investor | 11.4598 | 3636364 | 3636364 | 2023-04-10 | |
Appelbaum (Kevin J) | Individual Investor | 7.5847 | 2406719 | -6250 | 2023-04-10 | LOW |
Mountain Crest Capital LLC | Corporation | 4.375 | 1388250 | 0 | 2023-04-10 | LOW |
Farallon Capital Management, L.L.C. | Hedge Fund | 2.203 | 699042 | -114514 | 2023-03-31 | MED |
Armanino (Andrew J) | Individual Investor | 1.4739 | 467692 | 303030 | 2023-04-10 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3818 | 438479 | 3700 | 2023-03-31 | LOW |
Parker (Geoffrey M) | Individual Investor | 1.2491 | 396363 | 303030 | 2023-04-10 | LOW |
Maule-Ffinch (Georgianna) | Individual Investor | 0.9238 | 293150 | 0 | 2023-04-10 | LOW |
Karbe (Frank L) | Individual Investor | 0.9216 | 292424 | 242424 | 2023-04-10 | MED |
Berman Mark A | Individual Investor | 0.7309 | 231939 | 0 | 2023-04-10 | LOW |
Carmona (Richard H. M.D.) | Individual Investor | 0.4841 | 153619 | 0 | 2023-04-10 | LOW |
Wynholds (Kristin) | Individual Investor | 0.3114 | 98819 | 0 | 2023-04-10 | LOW |
Heinen (Mark) | Individual Investor | 0.2773 | 88004 | 1 | 2023-04-10 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2523 | 80054 | 798 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.18 | 57109 | 0 | 2023-03-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.1497 | 47516 | -6473 | 2023-03-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1424 | 45200 | 0 | 2023-03-31 | LOW |
Zamirowski (Justin) | Individual Investor | 0.1163 | 36913 | 36913 | 2022-05-27 | |
Millennium Management LLC | Hedge Fund | 0.0837 | 26556 | 14932 | 2023-03-31 | HIGH |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
548 Market St. #49404
SAN FRANCISCO
CALIFORNIA 94101
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 530.000 多名交易者,選擇與 Capital.com 交易